‘…and C is for Clioquinol’ – the AβCs of Alzheimer's disease
- 1 March 2002
- journal article
- research article
- Published by Elsevier in Trends in Neurosciences
- Vol. 25 (3) , 121-123
- https://doi.org/10.1016/s0166-2236(00)02086-5
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's diseaseProceedings of the National Academy of Sciences, 2001
- Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic MicePublished by Elsevier ,2001
- Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's diseaseNature, 2000
- Nasal administration of amyloid-? peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's diseaseAnnals of Neurology, 2000
- Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer diseaseNature Medicine, 2000
- Cu(II) Potentiation of Alzheimer Aβ NeurotoxicityJournal of Biological Chemistry, 1999
- Aqueous Dissolution of Alzheimer's Disease Aβ Amyloid Deposits by Biometal DepletionJournal of Biological Chemistry, 1999
- Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouseNature, 1999
- The Aβ Peptide of Alzheimer's Disease Directly Produces Hydrogen Peroxide through Metal Ion ReductionBiochemistry, 1999
- Dramatic Aggregation of Alzheimer Aβ by Cu(II) Is Induced by Conditions Representing Physiological AcidosisJournal of Biological Chemistry, 1998